Key result
Eosinophilic myocarditis was identified in 7.4% of explanted hearts, but 8-year postoperative survival was similar between patients with and without the condition.
Why the study?
What is the prevalence, potential cause, and prognostic impact of eosinophilic myocarditis in patients awaiting heart transplantation?
Observational (n=190)
No
What is the prevalence, potential cause, and prognostic impact of eosinophilic myocarditis in patients awaiting heart transplantation?
Eosinophilic myocarditis is present in approximately 7% of explanted hearts, likely related to hypersensitivity to preoperative medications such as inotropes, but it does not adversely affect long-term post-transplant survival.
Answers are grounded in this paper and cite their sources.
Eosinophilic myocarditis does not worsen post-transplant survival; leaves open its etiology and preoperative management in advanced HF.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Takkenberg et al. (2004) conducted an observational in Patients awaiting heart transplantation (n=190). Eosinophilic myocarditis vs. No eosinophilic myocarditis was evaluated on Postoperative survival at 8 years (p=0.34). Eosinophilic myocarditis was identified in 7.4% of explanted hearts, but 8-year postoperative survival was similar between patients with and without the condition.
Synapse has enriched 10 related papers. Consider them for comparative context: